Veronique Calleja, CSO and Laura Camacho, Senior Scientist from HAWK Biosystems will attend the congress, presenting a flash talk on their research abstract, “Quantification of PD-1/PD-L1 Functional Engagement by QF-Pro® as a Predictor of Immune Checkpoint Inhibitor Response in NSCLC.” This talk will focus on QF-Pro’s® potential as a valuable tool for predicting responses in non-small cell lung cancer (NSCLC) therapy. The ASEICA congress offers an important platform for dialogue between preclinical and clinical scientists, advancing innovative approaches to cancer treatment.